ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Avenue Therapeutics Inc

Avenue Therapeutics Inc (ATXI)

1,34
-0,05
(-3,60%)
Fermé 30 Janvier 10:00PM
1,31
-0,03
(-2,24%)
Après les heures de négociation: 1:23AM

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
1,31
Prix Achat
1,31
Prix Vente
1,37
Volume échangé
122 936
1,30 Fourchette du Jour 1,4293
1,26 Plage de 52 semaines 15,00
Cap du marché
Clôture Veille
1,39
Ouverture
1,38
Dernière Transaction
348
@
1.31
(formt)
Dernière heure de transaction
Volume financier
US$ 169 503
VWAP
1,3788
Volume moyen (3 m)
413 031
Actions en circulation
1 911 633
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,24
Bénéfice par action (BPA)
-5,43
Chiffre d'affairess
-
Bénéfice net
-10,38M

À propos de Avenue Therapeutics Inc

Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain. Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain.

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
Siège social
Dover, Delaware, USA
Fondé
-
Avenue Therapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker ATXI. Le dernier cours de clôture d'Avenue Therapeutics était de US$1,39. Au cours de la dernière année, les actions de Avenue Therapeutics ont été négociées dans une fourchette de prix de US$ 1,26 à US$ 15,00.

Avenue Therapeutics compte actuellement 1 911 633 actions en circulation. La capitalisation boursière d'Avenue Therapeutics est de US$2,66 million. Avenue Therapeutics a un ratio cours/bénéfice (ratio PE) de -0.24.

ATXI Dernières nouvelles

Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

MIAMI, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization...

Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit

MIAMI, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.54-29.18918918921.852.061.2651129541.87538014CS
4-0.69-34.522.22891.2613478861.876345CS
12-0.94-41.77777777782.252.40831.264130311.87870037CS
26-1.35-50.75187969922.663.541.262051191.93665412CS
52-9.94-88.355555555611.25151.265686208.81675806CS
156-808.69-99.83827160498101406.251.261795352309.07786777CS
260-11124.94-99.98822604211126.25141301.261167609685.98732933CS

ATXI - Frequently Asked Questions (FAQ)

What is the current Avenue Therapeutics share price?
The current share price of Avenue Therapeutics is US$ 1,31
How many Avenue Therapeutics shares are in issue?
Avenue Therapeutics has 1 911 633 shares in issue
What is the market cap of Avenue Therapeutics?
The market capitalisation of Avenue Therapeutics is USD 2,66M
What is the 1 year trading range for Avenue Therapeutics share price?
Avenue Therapeutics has traded in the range of US$ 1,26 to US$ 15,00 during the past year
What is the PE ratio of Avenue Therapeutics?
The price to earnings ratio of Avenue Therapeutics is -0,24
What is the reporting currency for Avenue Therapeutics?
Avenue Therapeutics reports financial results in USD
What is the latest annual profit for Avenue Therapeutics?
The latest annual profit of Avenue Therapeutics is USD -10,38M
What is the registered address of Avenue Therapeutics?
The registered address for Avenue Therapeutics is 3500 S DUPONT HWY, KENT, DOVER, DELAWARE, 19901
What is the Avenue Therapeutics website address?
The website address for Avenue Therapeutics is www.avenuetx.com
Which industry sector does Avenue Therapeutics operate in?
Avenue Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
DGNXDiginex Ltd
US$ 49,18
(228,09%)
3,34M
SLXNSilexion Therapeutics Corporation
US$ 3,1301
(131,86%)
330,45M
KRKR36Kr Holdings Inc
US$ 9,10
(114,12%)
23,61M
SPGCSacks Parente Golf Inc
US$ 0,6001
(57,92%)
52,17M
XFORX4 Pharmaceuticals Inc
US$ 0,7542
(56,54%)
42,5M
ZKINZK International Group Co Ltd
US$ 0,4813
(-41,21%)
3,1M
MGOLMGO Global Inc
US$ 0,1019
(-38,73%)
70,52M
BACKIMAC Holdings Inc
US$ 0,7869
(-35,50%)
2,37M
EYENEyenovia Inc
US$ 0,03695
(-35,18%)
25,31M
HAOHaoxi Health Technology Ltd
US$ 2,52
(-31,89%)
484,94k
NVDANVIDIA Corporation
US$ 123,70
(-4,10%)
466,94M
SLXNSilexion Therapeutics Corporation
US$ 3,1301
(131,86%)
330,45M
OCEAOcean Biomedical Inc
US$ 0,249929
(-24,26%)
186,52M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,428
(-6,98%)
148,12M
RIMEAlgorhythm Holdings Inc
US$ 0,0259
(-16,18%)
138,96M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock